XNAS · Laboratory Analytical Instruments · S&P 500
$4.68
+$0.26 (+5.88%) today
Open $4.42 High $4.94 Low $4.42 Vol 513K Avg $4.75
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| LMRI | Lumexa Imaging Holdings, Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| AMS | American Shared Hospital Services | XASE | USD | SERVICES-MEDICAL LABORATORIES |
| SERA | Sera Prognostics, Inc. Class A Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| CSTL | Castle Biosciences, Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| ACON | Aclarion, Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| XGN | Exagen Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
52-week price range
Price is 80.7% above its 52-week low and 61.7% below its 52-week high. Trading in the lower half of its annual range — closer to the floor than the ceiling.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.